Literature DB >> 33257172

Engagement of phytoestrogens in breast cancer suppression: Structural classification and mechanistic approach.

Ankur Kumar Tanwar1, Neha Dhiman1, Amit Kumar1, Vikas Jaitak2.   

Abstract

Cancer is the world's devastating disease, and breast cancer is the most common reason for the death of women worldwide. Many synthetic drugs and medications are provided with their beneficial actions, but all of these have side effects and resistance problems. Natural remedies are coming forward to overcome the disadvantages of synthetic drugs. Among the natural categories, phytoestrogens having a structural similarity of mammalian oestradiol proves its benefit with various mechanisms not only in the treatment of breast cancer but even to prevent the occurrence of postmenopausal symptoms. Phytoestrogens are plant-derived compounds that were utilized in ancient medications and traditional knowledge for its sex hormone properties. Phytoestrogens exert pleiotropic effects on cellular signalling and show effects on estrogen-dependent diseases. However, because of activation/inhibition of steroid hormonal receptor ER-α or ER-β, these compounds induce or inhibit steroid hormonal (estrogen) action and, therefore, have the potential to disrupt hormone (estrogen) signalling pathway. In this review, we have discussed and summarize the effect of certain phytoestrogens and their possible mechanisms that can substantiate advantageous benefits for the treatment of post-menopausal symptoms as well as for breast cancer.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Estrogen receptor (ER); Flavonoids; Lignans; MOA; Oestradiol; Phytoestrogens (PEs)

Mesh:

Substances:

Year:  2020        PMID: 33257172     DOI: 10.1016/j.ejmech.2020.113037

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

Review 1.  GENETICS IN ENDOCRINOLOGY: Impact of race and sex on genetic causes of aldosterone-producing adenomas.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Eur J Endocrinol       Date:  2021-05-21       Impact factor: 6.664

Review 2.  Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer.

Authors:  Chandra K Maharjan; Jiao Mo; Lei Wang; Myung-Chul Kim; Sameul Wang; Nicholas Borcherding; Praveen Vikas; Weizhou Zhang
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 3.  Pharmacological Properties to Pharmacological Insight of Sesamin in Breast Cancer Treatment: A Literature-Based Review Study.

Authors:  Md Sohel; Md Nurul Islam; Md Arju Hossain; Tayeba Sultana; Amit Dutta; Md Sohanur Rahman; Suraiya Aktar; Khairul Islam; Abdullah Al Mamun
Journal:  Int J Breast Cancer       Date:  2022-02-17

4.  Electrospun Poly(lactide) Fibers as Carriers for Controlled Release of Biochanin A.

Authors:  Ivana Gajić; Sanja Stojanović; Ivan Ristić; Snežana Ilić-Stojanović; Branka Pilić; Aleksandra Nešić; Stevo Najman; Ana Dinić; Ljiljana Stanojević; Maja Urošević; Vesna Nikolić; Ljubiša Nikolić
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.